Assessment Training Programs
![UPDRS Part I questions 1 and 2 [2]. | Download Scientific Diagram](https://www.researchgate.net/publication/351975927/figure/fig1/AS:1080189173923849@1634548576236/UPDRS-Part-I-questions-1-and-2-2.jpg "UPDRS Part I questions 1 and 2 [2]. | Download Scientific Diagram")
UPDRS Part I questions 1 and 2 [2]. | Download Scientific Diagram
Table 1 from The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease. | Semantic Scholar
Virtual exam for Parkinson's disease enables frequent and reliable remote measurements of motor function | npj Digital Medicine
Parkinson's Disease Center at BIDMC on X: "A GLP1 agonist, NLY01, did not meet the primary outcome in a ph2 study in #PD, but a pre-specified analysis showed significant benefits for both
Correlation Between PDQ-39 and MDS-UPDRS Scores in a Phase 3 Randomized Controlled Trial of Patients with Parkinson's Disease - MDS Abstracts
Some exciting GLP-1 drug new randomized trial evidence for potential disease-modifying impact on #Parkinson's disease (there are none). No progression of motor disability in the Rx group for 12 months. https://nejm.org/doi/full/10.1056/NEJMoa2312323
![PDF] SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson's disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3b30592ca82ccdf0a1c52a5e8183eeb27adcb6ba/2-Table1-1.png "PDF] SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson's disease. | Semantic Scholar")
PDF] SPES/SCOPA and MDS-UPDRS: formulas for converting scores of two motor scales in Parkinson's disease. | Semantic Scholar
Understanding MDS-UPDRS Parkinson's Assessment | PDF
Demographics and treatment effects for the UPDRS ADL (part II) plus... | Download Table
MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
Unified Parkinson's Disease Rating Scale (UPDRS) & Example | Free PDF Download
Frontiers | Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia
Figure 1 from A MDS-UPDRS Part II (motor experiences of daily living) score to predict recurrent falls in people with Parkinson's disease | Semantic Scholar
Video-based automated analysis of MDS-UPDRS III parameters in Parkinson disease | bioRxiv
Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson's disease | Journal of Neural Transmission
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort | Journal of Neurology
A Phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease (PASADENA): rationale, design and baseline data | medRxiv
JCI - Exenatide and the treatment of patients with Parkinson's disease
UPDRS II and III scores in the first stage of the trial and at 1, 3, 6,... | Download Table
Weighting MDS-UPDRS Part II items for optimal sensitivity to Parkinson's disease progression using Parkinson's Progression M
Table 2 from The MDS-UPDRS Part II (motor experiences of daily living) resulted useful for assessment of disability in Parkinson's disease. | Semantic Scholar
We need to talk about the UPDRS – The Science of Parkinson's
